Outcomes of Immune Checkpoint Inhibitors in Patients with Cancer and a Poor Performance Status #445.

Journal of Palliative MedicineVol. 25, No. 9 Fast Facts and ConceptsOutcomes of Immune Checkpoint Inhibitors in Patients with Cancer and a Poor Performance Status #445Alyssa Scher, Camilla Melegari, and Ramy SedhomAlyssa ScherSearch for more papers by this author, Camilla MelegariSearch for more papers by this author, and Ramy SedhomAddress correspondence to: Ramy Sedhom, MD, Penn Medicine—Princeton Medicine Physicians, Hematology/Oncology, Prince Medical Center, Medical Arts Pavilion, Suite 540, 5 Plainsboro Road, Plainsboro, NJ 08536, USA E-mail Address: sedhomr@gmail.comhttps://orcid.org/0000-0001-8937-0726Search for more papers by this authorPublished Online:30 Aug 2022https://doi.org/10.1089/jpm.2022.0275AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 25Issue 9Sep 2022 InformationCopyright 2022, Mary Ann Liebert, Inc., publishersTo cite this article:Alyssa Scher, Camilla Melegari, and Ramy Sedhom.Outcomes of Immune Checkpoint Inhibitors in Patients with Cancer and a Poor Performance Status #445.Journal of Palliative Medicine.Sep 2022.1440-1442.http://doi.org/10.1089/jpm.2022.0275Published in Volume: 25 Issue 9: August 30, 2022PDF download